Discover variants in 46 cancer genes using the Ion AmpliSeq™ Cancer Panel v1
17 July 2013
Targeted resequencing can be utilized for efficient interrogation of specific genes or genomic regions. Current target selection methods are lengthy, and complex, and usually require large amounts of input DNA. Truly effective translational research depends on the development of rapid approaches that deliver reliable results from small amounts of sample material and from challenging research samples such as formalin-fixed, paraffin-embedded (FFPE) tissues. Download this application note to read about Ion AmpliSeq™ target selection technology, a workflow that overcomes most known barriers to multiplex PCR, enabling the rapid sequencing of hundreds of known mutations for low-frequency allele detection or germline mutation detection.